Unbound MEDLINE

Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys. Biopharmaceutics & drug disposition [Biopharm Drug Dispos] Journal article

 
TitlePharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys.
Author(s)Du Y, Tian H, Gao XD, Yao WB 
InstitutionSchool of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
SourceBiopharm Drug Dispos 2008 Nov 4.
AbstractThe pharmacokinetic properties of a branched 40 kDa polyethylene glycol (PEG) conjugate formulation of consensus interferon-alpha (CIFN) was evaluated in rhesus monkeys following subcutaneous administration. Four groups of rhesus monkeys (n=6 per group) received 1250, 300 and 150 microg/kg of PEG-CIFN and 150 microg/kg CIFN, respectively. Serum concentrations of the interferons were measured with an antiviral activity assay at various time points after administration. The PK profiles of the pooled data were described by a noncompartmental method. Peak concentration of PEG-CIFN was observed at 27-31 h, followed by a prolonged decay in comparison with the unmodified CIFN, the PEG-CIFN had a 4-5-fold longer terminal half-life. The apparent clearance (dose(sc)/AUC) decreased from 150 mL/h/kg for CIFN to 19.0-45.5 mL/h/kg for PEG-CIFNs. The AUC was lower for PEG-CIFN than that for CIFN at the 150 microg/kg. Copyright (c) 2008 John Wiley & Sons, Ltd.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18985796
  
Advertise on this site.